From: The emerging role of histone lysine demethylases in prostate cancer
GENE | ROLE IN PROSTATE CANCER | REF. |
---|---|---|
KDM1A | Oncogene, AR co-activator, associated with higher relapse risk | 25-28 |
KDM2A | Putative tumor suppressor, reduced expression in PCa | 41 |
KDM3A | Putative oncogene, overexpressed in PCa, AR co-activator | 30, 33 |
KDM4A | Overexpressed in PCa | 33 |
KDM4B | Overexpressed in PCa | 33 |
KDM4C | Putative oncogene, overexpressed in CRPC, AR co-activator | 30-32 |
KDM5B | Overexpressed in metastatic PCa, AR-co-activator | 35 |
KDM5C | Putative oncogene, overexpressed in PCa, suppresses TGFB signalling | 36 |
KDM6B | Putative oncogene, overexpressed in metastatic PCa | 38 |
PHF8 | Putative oncogene, overexpressed in PCa, mediates cell invasion | 33 |